Ault Milton C III 的 Form 4 申報
Alzamend Neuro, Inc.（ALZN），2022/5/13 申報
- 申報編號
- 0001214659-22-006832
- 申報時間
- 2022/5/13
- 交易日
- 2022/5/6-5/12
- 申報延遲
- 7 天遲報
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 2 筆非衍生性交易。公開市場買進合計 $12.1 萬。交易後 7 天才申報，超過 2 個營業日的期限。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Ault Milton C IIICIK 0001212502 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.9998. The range of purchase prices on the transaction date was $0.9915 to $0.9999 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
表 I 有 1 筆交易的價格引用這則附註。
- F2
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.8527. The range of purchase prices on the transaction date was $0.8361 to $8568 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
表 I 有 1 筆交易的價格引用這則附註。